home
ABOUT
company profile
Strategy
Management Team & Board Of Directors
Products
PRF-110
Product Pipeline
Clinical Trials
Market
Investors
press releases
sec filling
presentations
events
governance
stock chart
Contact
Menu
home
ABOUT
company profile
Strategy
Management Team & Board Of Directors
Products
PRF-110
Product Pipeline
Clinical Trials
Market
Investors
press releases
sec filling
presentations
events
governance
stock chart
Contact
Investor relations
Investors lobby
company profile
press releases
presentations
events
governance
stock chart
Sec Filings
Contact
Menu
Investors lobby
company profile
press releases
presentations
events
governance
stock chart
Sec Filings
Contact
press releases
04/18/2024
PainReform Announces Closing of $4 Million Public Offering
read more
04/09/2024
PainReform’s Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions
read more
04/02/2024
PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in Bunionectomy
read more
03/01/2024
PainReform Provides Year-End Business Update
read more
01/22/2024
PainReform to Present at the Microcap Conference in Atlantic City
read more
01/03/2024
PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief
read more